美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,492.17

+31.152.13%

漲家數：5

跌家數：2

平家數：- -

市盈率：- -

高：1,493.70

開：1,460.44

低：1,460.44

收：1,461.02

資料載入中...

總覽新聞資訊

碩迪生物盤中異動早盤股價大跌5.42%

輝瑞天價併購獲得的產品，如今是賺還是虧？

Insight数据库

非洲製藥商 Aspen 稱新的拉塔姆和禮來產品組合提高了收益

輝瑞公司首席執行官表示，輝瑞可能將外部生產基地遷至美國

Altimmune, Inc.盤中異動股價大跌5.04%

輝瑞(PFE.N)高管：如果有顯著的關税，公司將努力將製造業務轉移至美國。

Viking Therapeutics, Inc.盤中異動早盤大幅下跌5.02%

碩迪生物盤中異動急速跳水5.01%報22.56美元

非洲製藥商 Aspen 半年盈利增長 5

諾和諾德的司美格魯肽，還能再大賣幾年？

【歐股“十一羅漢”｜2月份阿斯麥跌6.1%，諾和諾德漲超6.1%，雀巢漲超12.4%】週五，阿斯麥控股荷蘭阿姆斯特丹股價收跌2.93%，報678.60歐元，本週累跌4.44%，2月份累跌6.10%。諾和諾德哥本哈根股價收漲0.42%，報644.50，本週累漲2.30%，2月份累漲6.13%。

碩迪生物盤中異動早盤大幅下挫5.30%

KBP將對諾和諾德申請獲得的禁令進行抗辯

百濟神州，正在走安進曾經的路

碩迪生物盤中異動急速上漲5.28%報20.93美元

Viking Therapeutics, Inc.盤中異動股價大漲5.03%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1492.1732,"timestamp":1741208399999,"preClose":1461.0245,"halted":0,"volume":58200771,"delay":0,"changeRate":0.02132,"change":31.148682,"pbRate":11.780703,"amount":5513579718.723701,"amplitude":0.02276,"prevYearClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"turnoverRate":0.005514,"marketCap":1606807813984,"floatMarketCap":1490733575264,"peRate":41.703544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1493.6967,"amplitude":0.02276,"preClose":1461.0245,"low":1460.4442,"pbRate":"11.780703","latestPrice":1492.1732,"volume":58200771,"delay":0,"open":1460.4442,"prevYearClose":1305.0607,"prevWeekClose":1482.1702,"prevMonthClose":1482.1702,"prevQuarterClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"sixtyDayClose":1441.3252,"secType":"PLATE","market":"US","turnoverRate":0.005514,"peRate":41.703544,"marketCap":1606807813984,"floatMarketCap":1490733575264,"timestamp":1741208399999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:16,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516714608","title":"碩迪生物盤中異動 早盤股價大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516714608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516714608?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 23:19","pubTimestamp":1741101575,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时19分，硕迪生物股票出现波动，股价快速下挫5.42%。截至发稿，该股报21.13美元/股，成交量10.8238万股，换手率0.19%，振幅4.89%。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231935a25f1345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231935a25f1345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2516612755","title":"輝瑞天價併購獲得的產品，如今是賺還是虧？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516612755","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516612755?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 08:03","pubTimestamp":1741046636,"startTime":"0","endTime":"0","summary":"获得的管线中，哪些成了辉瑞新的增长动力？辉瑞需要通过伊曲莫德未来的表现，来体现这次收购的价值。当时已经上市的沃塞洛托，因为最新临床数据中，出现了高于预期的死亡率事件，如今已经撤市。总的来说，辉瑞通过收购成熟产品，快速补强了管线，尤其在肿瘤、偏头痛领域，都已经兑现了价值，但自免领域和血液罕见病领域，目前还处于消化期，未来给辉瑞带来多少销售增量，还需要时间来验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304135745abe74147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304135745abe74147&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","SG9999003800.SGD","BK4581","LU1894683348.USD","BK4588","LU0225771236.USD","BK4533","LU0868494617.USD","SG9999013999.USD","LU0058720904.USD","LU1894683264.USD","SG9999001176.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU0321505439.SGD","LU0289739699.SGD","SG9999001176.SGD","BK4007","IE00B19Z3B42.SGD","IE0002270589.USD","LU0321505868.SGD","LU1066053197.SGD","IE00B19Z3581.USD","BK4568","BK4534","LU0306807586.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU1883839398.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0122379950.USD","BK4592","SGXZ57979304.SGD","LU1057294990.SGD","BK4599","LU0985481810.HKD","LU0306806265.USD","PFE","IE000M9KFDE8.USD","LU0456855351.SGD","LU1066051498.USD","SG9999002232.USD","SG9999011175.SGD","IE00BBT3K403.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2516656979","title":"非洲製藥商 Aspen 稱新的拉塔姆和禮來產品組合提高了收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2516656979","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516656979?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 01:10","pubTimestamp":1741021857,"startTime":"0","endTime":"0","summary":"更新版 1-更新 1-非洲制药商 Aspen 称新的拉塔姆和礼来产品组合提高了收益添加 GLP-1 药物详情和首席执行官对 Mounjaro 的全程评论Nqobile Dludla路透社约翰内斯堡3月3日 - Aspen Pharmacare APNJ.J周一公布的半年盈利增长了5%，并表示受益于拉丁美洲的产品组合和减肥药Mounjaro的推出，预计全年其商业制药部门的收入和核心利润将有两位数的增长。这家总部位于南非的制药公司正在大力争取一类名为 GLP-1 类似物的药物合同，用于治疗糖尿病和减肥。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3S3PM1AV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","IE00B1BXHZ80.USD","LU2237443622.USD","LLY","BK4007","LU1366192091.USD","BK4599","LU2023250504.SGD","LU2265009873.SGD","SG9999014880.SGD","SG9999015986.USD","LU2491050071.SGD","SGXZ81514606.USD","SGXZ57979304.SGD","LU0061475181.USD","LU1989771016.USD","SGXZ51526630.SGD","LU0354030511.USD","LU0820561818.USD","VTRS","IE00BJT1NW94.SGD","LU0079474960.USD","SG9999015952.SGD","LU1093756168.USD","LU0820561909.HKD","LU1868836914.USD","SG9999017495.SGD","LU0122379950.USD","LU0289739699.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU2602419157.SGD","LU0354030438.USD","IE00BJJMRZ35.SGD","LU1804176565.USD","LU1988902786.USD","IE00BFTCPJ56.SGD","LU1814569148.SGD","LU2468319806.SGD","IE00BK4W5L77.USD","LU1023059063.AUD","LU0882574139.USD","LU2357305700.SGD","LU1551013342.USD","IE0009355771.USD","SG9999015945.SGD","LU2237443465.HKD","LU2361044865.SGD","BK4534","LU0256863902.USD"],"gpt_icon":1},{"id":"2516658185","title":"輝瑞公司首席執行官表示，輝瑞可能將外部生產基地遷至美國","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658185","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516658185?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:56","pubTimestamp":1741017395,"startTime":"0","endTime":"0","summary":"辉瑞公司首席执行官表示，辉瑞可能将外部生产基地迁至美国路透社3月3日 - 辉瑞PFE.N首席执行官阿尔伯特-布尔拉（Albert Bourla）周一表示，由于唐纳德-特朗普（Donald Trump）总统的政府威胁要对进口商品征收大量关税，制药商可能会在必要时将海外生产转移到美国。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3T3PM175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1023059063.AUD","SG9999002232.USD","BK4592","LU0456855351.SGD","BK4581","LU0234572021.USD","LU0868494617.USD","LU1066053197.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU0306807586.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","SG9999011175.SGD","BK4550","BK4588","LU0289739699.SGD","LU0058720904.USD","LU1894683264.USD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","LU0122379950.USD","LU0321505439.SGD","BK4585","IE00BLSP4452.SGD","BK4568","PFE","IE00BLSP4239.USD","IE00B19Z3B42.SGD","SG9999001176.USD","BK4534","BK4533","BK4599","LU0321505868.SGD","SG9999013999.USD","SG9999001176.SGD","BK4007","LU1883839398.USD","IE00B19Z3581.USD","IE0002270589.USD","SG9999002224.SGD","LU1066051498.USD"],"gpt_icon":0},{"id":"2516580806","title":"Altimmune, Inc.盤中異動 股價大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516580806?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:53","pubTimestamp":1741017238,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分，Altimmune, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报6.32美元/股，成交量54.6719万股，换手率0.77%，振幅5.19%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2916.94%、141.90%、133.69%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","BK4599","ALT"],"gpt_icon":0},{"id":"2516163074","title":"輝瑞(PFE.N)高管：如果有顯著的關税，公司將努力將製造業務轉移至美國。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516163074","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516163074?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:39","pubTimestamp":1741016341,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4534","SGXZ57979304.SGD","LU0321505868.SGD","LU0058720904.USD","BK4581","LU0225284248.USD","LU0234572021.USD","LU1023059063.AUD","LU0170899867.USD","LU1057294990.SGD","BK4568","LU1066053197.SGD","LU1894683348.USD","IE00BBT3K403.USD","LU0306807586.USD","SG9999002232.USD","LU1883839398.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00B19Z3581.USD","BK4599","SG9999002224.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4533","BK4550","LU1894683264.USD","IE0002270589.USD","LU0985481810.HKD","BK4588","BK4592","IE000M9KFDE8.USD","LU0225771236.USD","BK4007","PFE","SG9999001176.SGD","LU0306806265.USD","LU1066051498.USD","LU0289739699.SGD","LU0321505439.SGD","IE00BLSP4239.USD","SG9999013999.USD","SG9999001176.USD","LU0456855351.SGD","LU0122379950.USD","LU0868494617.USD","BK4585"],"gpt_icon":0},{"id":"2516263769","title":"Viking Therapeutics, Inc.盤中異動 早盤大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516263769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516263769?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 22:52","pubTimestamp":1741013569,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时52分，Viking Therapeutics, Inc.股票出现异动，股价急速下挫5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、木薯科学涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为687.62%、115.08%、86.65%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、40.78%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225249989a15a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225249989a15a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","VKTX","BK4585","LENZ","BK4599","BK4139"],"gpt_icon":0},{"id":"2516634444","title":"碩迪生物盤中異動 急速跳水5.01%報22.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516634444?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 22:42","pubTimestamp":1741012932,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时42分，硕迪生物股票出现波动，股价大幅下挫5.01%。截至发稿，该股报22.56美元/股，成交量5.9494万股，换手率0.10%，振幅4.53%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.23亿美元，每股收益-2.33美元，毛利-2.60百万美元，市盈率-9.65倍。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224212abe636c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224212abe636c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2516680900","title":"非洲製藥商 Aspen 半年盈利增長 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2516680900","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516680900?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 20:20","pubTimestamp":1741004423,"startTime":"0","endTime":"0","summary":"更新 1-非洲制药商 Aspen 半年盈利增长 5第 1 段增加了商业制药展望，第 3-5 段增加了业绩和过去的交易路透社约翰内斯堡3月3日 - Aspen Pharmacare APNJ.J周一公布的半年财报显示，该公司 半年盈利增长了5%，并称  受益于拉美地区的产品组合和Mounjaro的推广， 预计  全年商业制药部门 的收入和核心利润将有两位数的增长  。在截至12月31日的六个月里，这家非洲最大的制药 公司的正常化每股净收益 为724.2南非分，高于上一年同期的688.3南非分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3S3PM0RW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1989771016.USD","LU0820561818.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU0106261372.USD","LU0320765059.SGD","LU0094547139.USD","LU1917777945.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","SG9999001176.SGD","LU2063271972.USD","BK4599","LU0203201768.USD","LU1291159041.SGD","SG9999014914.USD","LU1280957306.USD","SG9999015945.SGD","IE00B4R5TH58.HKD","LU0079474960.USD","IE00BJJMRZ35.SGD","LU1366192091.USD","SG9999001176.USD","LU2357305700.SGD","LU1057294990.SGD","LU1868836757.USD","IE00B1BXHZ80.USD","LU0203202063.USD","LU1814569148.SGD","LU2237443978.SGD","LU0061475181.USD","SGXZ99366536.SGD","LU2361044949.HKD","LU2361044865.SGD","LU2087621335.USD","LU0058720904.USD","VTRS","LU0198837287.USD","IE0009355771.USD","LU0256863811.USD","SG9999014880.SGD","LU1064131342.USD","SGXZ51526630.SGD","BK4583","LU1983299246.USD","LU0238689110.USD","BK4581","LU1551013342.USD"],"gpt_icon":1},{"id":"2516540532","title":"諾和諾德的司美格魯肽，還能再大賣幾年？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516540532","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516540532?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 06:02","pubTimestamp":1740952935,"startTime":"0","endTime":"0","summary":"然而在产品生命周期越来越短的今天，司美格鲁肽还能再大卖几年？除此之外也有多家公司宣布在司美格鲁肽原料药的生产过程取得重大进展。其中九源基因于2024年4月2号递交了司美格鲁肽注射液的上市申请并获受理，为国内首家，但遗憾的是，根据2024年12月31日药品通知件送达信息显示，九源基因的司美格鲁肽注射液未获批准上市。来自其他多肽的挑战目前，司美格鲁肽注射液在全球最大的竞争对手毫无疑问是礼来的替尔泊肽。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303060717a25c0b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303060717a25c0b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532","BK4007","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","BK4588","LU0154236417.USD","NVO","BK4599"],"gpt_icon":1},{"id":"2516086573","title":"【歐股“十一羅漢”｜2月份阿斯麥跌6.1%，諾和諾德漲超6.1%，雀巢漲超12.4%】 週五，阿斯麥控股荷蘭阿姆斯特丹股價收跌2.93%，報678.60歐元，本週累跌4.44%，2月份累跌6.10%。諾和諾德哥本哈根股價收漲0.42%，報644.50，本週累漲2.30%，2月份累漲6.13%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516086573","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516086573?lang=zh_tw&edition=fundamental","pubTime":"2025-03-01 02:32","pubTimestamp":1740767563,"startTime":"0","endTime":"0","summary":"周五，阿斯麦控股荷兰阿姆斯特丹股价收跌2.93%，报678.60欧元，本周累跌4.44%，2月份累跌6.10%。诺和诺德哥本哈根股价收涨0.42%，报644.50，本周累涨2.30%，2月份累涨6.13%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01023248470084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BD6J9T35.USD","LU0097036916.USD","BK4543","LU2063271972.USD","NVO","LU1093756168.USD","LU1734074674.USD","03165","NSRGY","IE00BKVL7J92.USD","LU1093756325.SGD","LU0823434740.USD","BK4599","BK4212","BK4588","LU0823434583.USD","IE0004445239.USD","IE00BZ1G4Q59.USD","BK4532","BK4007","LU0154236417.USD","ASML","BK4147","BK4585"],"gpt_icon":0},{"id":"2514202073","title":"碩迪生物盤中異動 早盤大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514202073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514202073?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 22:41","pubTimestamp":1740753666,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时41分，硕迪生物股票出现异动，股价快速下挫5.30%。截至发稿，该股报21.61美元/股，成交量6.7562万股，换手率0.12%，振幅8.63%。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224107a25803e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224107a25803e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2514836139","title":"KBP將對諾和諾德申請獲得的禁令進行抗辯","url":"https://stock-news.laohu8.com/highlight/detail?id=2514836139","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514836139?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:29","pubTimestamp":1740706181,"startTime":"0","endTime":"0","summary":"SICC于2025年2月14日批准了诺和诺德公司针对KBP及其创始人黄振华博士申请的禁令。KBP表示，SICC的裁决是在公司及创始人黄振华不知情、未参与的情况下，在诺和诺德单方面申请后作出的。KBP创始人兼董事长黄振华表示，诺和诺德提出的严重指控毫无根据；Ocedurenone有着巨大的潜力，公司仍一如既往地支持其发展。KBP称，其及黄振华将有机会在新加坡法院陈述立场，并已聘请法律顾问。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228092941abe00183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228092941abe00183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU1093756325.SGD","BK4588","IE00BKVL7J92.USD","BK4532","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4585","BK4599","NVO"],"gpt_icon":1},{"id":"2514350322","title":"百濟神州，正在走安進曾經的路","url":"https://stock-news.laohu8.com/highlight/detail?id=2514350322","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514350322?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 07:28","pubTimestamp":1740698880,"startTime":"0","endTime":"0","summary":"随着百济神州2024年财报的披露，其再次向市场深化了“创新药一哥”的定位。无论是市值规模，还是产品成熟度，百济神州显然与安进都不是一个等级的对手，简单静态对比并不能得出什么有效结论。如果以此视角推测，虽然不能说百济神州估值过高，但也应警惕如当年安进估值回落盘整的风险。如果说百济神州正在走安进曾经的路，那么长达十二年的潜在瓶颈期才是最考验投资者认知的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808161998958181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808161998958181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","BK4533","IE00BJT1NW94.SGD","LU0868494617.USD","BK4534","IE00BFTCPJ56.SGD","LU0058720904.USD","ONC","BK4585","LU1571399168.USD","LU0109394709.USD","IE00B2B36J28.USD","LU2242646821.SGD","BK4139","06160","BK4599","AMGN","IE0002141913.USD","LU0320765992.SGD","LU0289739699.SGD","LU1023059063.AUD","LU0889565916.HKD","BK4566","SG9999001440.SGD","IE0009355771.USD","LU0122379950.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU1983299246.USD","LU2242652126.USD","BK4581","LU2112291526.USD","BK4588","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2514158339","title":"碩迪生物盤中異動 急速上漲5.28%報20.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514158339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514158339?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 02:59","pubTimestamp":1740682791,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时59分，硕迪生物股票出现异动，股价快速拉升5.28%。截至发稿，该股报20.93美元/股，成交量51.5012万股，换手率0.90%，振幅5.81%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228025952a256b6e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228025952a256b6e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2514038900","title":"Viking Therapeutics, Inc.盤中異動 股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514038900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514038900?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:23","pubTimestamp":1740669804,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时23分，Viking Therapeutics, Inc.股票出现异动，股价大幅上涨5.03%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Quoin Pharmaceuticals Ltd、Alpha Tau Medical Ltd C/Wts 、Editas Medicine, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为884.66%、177.60%、104.83%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为74.16%、43.51%、34.80%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227232324abdf7c41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227232324abdf7c41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","BK4599","BK4139","VKTX","BK4588"],"gpt_icon":0}],"pageSize":16,"totalPage":7,"pageCount":2,"totalSize":109}]}}